Nitecapone

Nitecapone

SCHEMBL7039409

CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O.CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 1.00
XDH P47989 1/20 0.61
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
HPGD P15428 1/20 0.60
RECQL P46063 1/20 0.60
FTO Q9C0B1 3/20 0.54
ABCC3 O15438 1/20 0.53
ABCC4 O15439 1/20 0.53
ABCB11 O95342 1/20 0.53
LMNA P02545 1/20 0.53
CYP2C9 P11712 1/20 0.53
COMT P21964 1/20 0.53
EGFR P00533 1/20 0.50
GLO1 Q04760 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitecapone SCHEMBL30489171 1.00 GPR35 (1.00) GPR35XDHMEN1KMT2AALDH1A1
Nitecapone SCHEMBL128420 1.00 GPR35 (1.00) GPR35XDHMEN1KMT2AALDH1A1
SCHEMBL8028708 0.92 GPR35 (0.85) GPR35XDHMEN1KMT2AALDH1A1
SCHEMBL7279195 0.88 GPR35 (0.78) GPR35XDHMEN1KMT2AALDH1A1
SCHEMBL7279188 0.88 GPR35 (0.78) GPR35XDHMEN1KMT2AALDH1A1
SCHEMBL8848344 0.86 GPR35 (0.76) GPR35XDHMEN1KMT2AALDH1A1
Tolcapone SCHEMBL4391775 0.84 TTR (0.73) GPR35XDHMEN1KMT2AALDH1A1
Nitecapone SCHEMBL6835167 0.83 GPR35 (0.70) GPR35XDHMEN1KMT2AALDH1A1
SCHEMBL7279215 0.82 GPR35 (0.70) GPR35MEN1KMT2AALDH1A1MAPT
SCHEMBL7287709 0.82 GPR35 (0.70) GPR35XDHMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964678-B1 USE OF COMT INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION OF DIABETIC VASCULAR DYSFUNCTIONS ORION YHTYMAE OYJ (FI) 2003-03-19 EP disclosed
US-6207706-B1 ADMINISTERING CATECHOL-O-METHYL TRANSFERASE (COMT) INHIBITORS FOR THERAPY AND PROPHYLAXIS OF DIABETIC VASCULAR DYSFUNCTIONS SUCH AS NEPHROPATHY, RETINOPATHY AND NEUROPATHY ORION-YHTYMA OYJ (FI) 2001-03-27 US disclosed
EP-0964678-A1 USE OF COMT INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION OF DIABETIC VASCULAR DYSFUNCTIONS Orion-yhtymä Oyj (FI) 1999-12-22 EP disclosed
WO-1998027973-A1 USE OF COMT INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION OF DIABETIC VASCULAR DYSFUNCTIONS Orion-Yhtymä Oyj (FI) 1998-07-02 WO disclosed